Thursday, April 04, 2019 2:22:28 PM
5,083 Series A shares issued and outstanding at December 31, 2018 and December 31, 2017.
$500 per share liquidation preference
--
--
Common stock, $0.001 par value, 600,000,000 shares authorized at December 31, 2018 and
December 31, 2017; 207,913,541 issued and outstanding at December 31, 2018 and
December 31, 2017 (Note 8)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM